Trulieve Cannabis (TCNNF) Operating Expenses (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Operating Expenses of $134.4 million in Q1 2026, down 15.96% quarter-over-quarter from $159.9 million in Q4 2025, and down 10.37% on a YoY basis from $149.9 million in Q1 2025.
Trulieve Cannabis (TCNNF) Operating Expenses (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Operating Expenses history runs 7 years deep, the most recent figure standing at $134.4 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 10.37% year-over-year to $134.4 million; the TTM figure through Mar 2026 stood at $552.1 million (down 13.75% YoY), while the FY2025 annual figure was $567.7 million, down 8.14% from the prior year.
- Operating Expenses was $134.4 million for Q1 2026 at Trulieve Cannabis, down from $159.9 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $432.9 million in Q2 2023 to a low of $119.6 million in Q3 2023.
- Historically, Operating Expenses has averaged $163.0 million across 5 years, with a median of $141.9 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 205.1% in 2023, then sank 69.53% in 2024.
- A 5-year view of Operating Expenses shows it stood at $151.9 million in 2022, then declined by 17.93% to $124.7 million in 2023, then soared by 48.96% to $185.7 million in 2024, then decreased by 13.91% to $159.9 million in 2025, then fell by 15.96% to $134.4 million in 2026.
- The last three Operating Expenses figures came in at $134.4 million (Q1 2026), $159.9 million (Q4 2025), and $127.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 475.11 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 96.91 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 134.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.36 Mn |
| Dec 31, 2025 | 159.87 Mn |
| Sep 30, 2025 | 127.62 Mn |
| Jun 30, 2025 | 130.29 Mn |
| Mar 31, 2025 | 149.89 Mn |
| Dec 31, 2024 | 185.71 Mn |
| Sep 30, 2024 | 172.66 Mn |
| Jun 30, 2024 | 131.89 Mn |
| Mar 31, 2024 | 127.70 Mn |
| Dec 31, 2023 | 124.67 Mn |
| Sep 30, 2023 | 119.60 Mn |
| Jun 30, 2023 | 432.93 Mn |
| Mar 31, 2023 | 133.04 Mn |
| Dec 31, 2022 | 151.90 Mn |
| Sep 30, 2022 | 196.05 Mn |
| Jun 30, 2022 | 141.90 Mn |
| Mar 31, 2022 | 151.28 Mn |
| Dec 31, 2021 | 143.97 Mn |
| Sep 30, 2021 | 87.67 Mn |
| Jun 30, 2021 | 68.19 Mn |